These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 480485)

  • 1. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma.
    Sadoughi N; Mlsna J; Guinan P; Rubenstone A
    Urology; 1982 Aug; 20(2):143-6. PubMed ID: 7051508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder.
    Lange PH; Limas C; Fraley EE
    J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report.
    Bergman S; Javadpour N
    J Urol; 1978 Jan; 119(1):49-51. PubMed ID: 621814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ; Williams JL; Gelsthorpe K
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS; Weinstein RS; Summers JL
    Am J Clin Pathol; 1982 Jun; 77(6):692-9. PubMed ID: 7091049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    Decenzo JM; Howard P; Irish CE
    J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific red cell adherence test in transitional cell carcinoma of the bladder before and after radiotherapy in patients with blood group A.
    Wolk FN; Bishop MC
    J Urol; 1983 Jul; 130(1):71-3. PubMed ID: 6345808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder.
    Gorelick JI; Oyasu R; Golmon ME; Grayhack JT
    Urology; 1984 Sep; 24(3):287-90. PubMed ID: 6474644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.